8-K/AAMENDMENTCIK 0001788028
Jasper Therapeutics, Inc. (JSPR, JSPRW)
Material event (8-K/A) filed .
Current report announcing a material event, such as an acquisition, executive change, or earnings release.
New to the 8-K/A? What it is and how to read oneFiling facts
- Accession number
- 0001213900-26-106574
- Filer
- Jasper Therapeutics, Inc. (JSPR, JSPRW)
- CIK
- 0001788028
- Form type
- 8-K/A
- Form description
- Material event
- Filed at
- October 5, 2026
- Industry
- SIC 2836Biological Products
- Last verified
- October 5, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from Jasper Therapeutics, Inc. (JSPR, JSPRW)
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1788028/000121390026106574/0001213900-26-106574-index.htm ↗Filer's full EDGAR submission history
EDGAR · Jasper Therapeutics, Inc. (JSPR, JSPRW) (0001788028) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001213900-26-106574.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.